Impact of East Coast fever on Grande Comore: assessment taking a participatory epidemiology approach

2018 ◽  
Vol 51 (1) ◽  
pp. 99-107
Author(s):  
F. Boucher ◽  
Y. Moutroifi ◽  
M. Ali ◽  
Y. Moindjie ◽  
M. Soulé ◽  
...  
2008 ◽  
pp. 1265-1265
Author(s):  
James C. Dunford ◽  
Louis A. Somma ◽  
David Serrano ◽  
C. Roxanne Rutledge ◽  
John L. Capinera ◽  
...  
Keyword(s):  

Parasitology ◽  
1910 ◽  
Vol 3 (2) ◽  
pp. 117-129 ◽  
Author(s):  
George H. F. Nuttall ◽  
H. B. Fantham

In an earlier paper (Nuttall, Fantham and Porter, 1909, Parasitology vol II. pp. 325—340), we recorded our observations on living Theileria parva as seen in the peripheral blood of two cows which succumbed to East Coast Fever1. We now propose to describe our studies upon the parasite in stained preparations made from the animals' blood during the course of the disease and from their organs shortly after death. We shall confine our attention to the types of parasites encountered within red blood corpuscles or to corresponding types which may be occasionally encountered free in the plasma. The subject of “Koch's blue bodies” will receive attention at a later date.


1974 ◽  
Vol 6 (3) ◽  
pp. 145-151 ◽  
Author(s):  
R. E. Purnell ◽  
A. D. Irvin ◽  
C. D. Kimber ◽  
P. L. Omwoyo ◽  
R. C. Payne

Author(s):  
Sammy Gichuhi Ndungu ◽  
Sebastian K. Waruri ◽  
James M. Wanjohi

East coast fever, a disease of cattle caused by the protozoan parasite Theileria parva and transmitted by the three-host tick Rhipicephalus appendiculatus (the brown ear tick), is a major constraint to cattle production in Eastern, Central, and Southern Africa. In Kenya it is the most important tick-borne disease and a major constraint in cattle productivity. This is due to the high morbidity and mortality it causes in susceptible herds, the cost of control of the vector ticks, and the cost of treatment of clinical cases. Animals that recover from the disease also suffer from reduced productivity which can be long term. The limited distribution of the tick and the disease to only East, Central and Southern Africa also means that the market for therapeutic drugs and acaricides is small. Therefore, drug companies are not keen on funding research and development of new drug and acaricide molecules when resistance occurs.


Sign in / Sign up

Export Citation Format

Share Document